Recent advances in galactose-engineered nanocarriers for the site-specific delivery of siRNA and anticancer drugs
- 1 May 2018
- journal article
- review article
- Published by Elsevier in Drug Discovery Today
- Vol. 23 (5) , 960-973
Abstract
No abstract availableKeywords
This publication has 85 references indexed in Scilit:
- Polymeric Micelles, a Promising Drug Delivery System to Enhance Bioavailability of Poorly Water-Soluble DrugsJournal of Drug Delivery, 2013
- Liposome: classification, preparation, and applicationsDiscover Nano, 2013
- Inactive-state preassembly of Gq-coupled receptors and Gq heterotrimersNature Chemical Biology, 2011
- Recent Advances in Lipid Nanoparticle Formulations with Solid Matrix for Oral Drug DeliveryAAPS PharmSciTech, 2010
- Inhibition binding studies of glycodendrimer/lectin interactions using surface plasmon resonanceTetrahedron, 2010
- Sustained Liver Targeting and Improved Antiproliferative Effect of Doxorubicin Liposomes Modified with Galactosylated Lipid and PEG-LipidAAPS PharmSciTech, 2010
- Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instabilityCarcinogenesis, 2009
- Current advances in research and clinical applications of PLGA-based nanotechnologyExpert Review of Molecular Diagnostics, 2009
- A nomenclature for ligand-gated ion channelsNeuropharmacology, 2009
- Oncogenes and CancerNew England Journal of Medicine, 2008